Background/Aims: MiRNAs may regulate neurogenic differentiation of adipose-derived stem cells (ADSCs). In this study, we hypothesized that the miR-142-5p can repress the expression of RhoA/ROCK1 pathway on the neurogenesis of ADSCs. Methods: Deregulated miRNA during neurogenic differentiation of ADSCs were identified. The expression of neuron-specific enolase (NSE) and β III tubulin (Neuron-specific class III beta-tubulin) were detected as the markers of neurogenic differentiation by immunostaining and western blot. The targeting of miR-142-5p on RhoA and ROCK1 was verified by dual luciferase assay, qRT-PCR and western blot. The roles of miR-142-5p and the RhoA/ROCK1 signaling pathway were explored by using functional experiments including cell viability and colony formation assays. Results: MiR-142-5p is significantly upregulated during neurogenic differentiation of ADSCs. Knockdown of endogenous miR-142-5p hampered neurogenic differentiation. MiR-142-5p could directly target RhoA and ROCK1 mRNA and repress their expressions, through which it increased the proportion of differentiated cells with positive NSE and β III tubulin. RhoA/ROCK1 signaling pathway is involved in miR-142-5p effect on the process of neurogenic differentiation of ADSCs. Conclusion: Our results demonstrate that miR-142-5p functions as a growth promotive miRNA and plays an important role in neurogenic differentiation by targeting RhoA/ROCK1 in ADSCs.
Introduction
Mesenchymal stromal cells (MSCs) can transdifferentiate into osteogenic, chondrogenic, adipogenic, myogenic, fibroblastic, and neuronal lineages, they are considered as a promising source of cellular therapy and regenerative medicine [1, 2] . In particular, Adipose-derived stem cells (ADSCs), isolated from adipose tissue, belong to the family of MSCs and can be differentiated into multiple lineages via chemical induction factors [3] . ADSCs share common genetic signals with bone marrow MSCs and provides some advantages over other sources of stem cells, such as abundant quantities, minimally invasive procedures for harvest, and autologous origins that will not require immunosuppression in future therapies [4] . ADSCs can differentiate to a variety of specialized cell types. Although differentiation of the ADSCs to neu ronal and glial lineages has been reported previously [5] , the mechanisms underlying the neurogenic differentiation of ADSCs remains elusive.
MicroRNAs (miRNAs) are a class of small noncoding RNAs involved in post transcriptional regulation of gene expression usually by binding to the 3' untranslated region (UTR) of mRNAs. Some recent studies indicate that multiple miRNAs might regulate neuronal-like differentiation of MSCs. MiR-21 has been confirmed to directly contribute to ADSCs differentiation [6] . MiR-210 increases ADSCs proliferation and migration via PTPN2 expression [7] . MiR-34a inhibits ADSCs differentiation by regulating the cell cycle and senescence induction [8] . The Let-7 family plays as a pre-differentiated factor with antistemness properties [9] . The functions of miR-26a, miR-181a, miR-222 and miR-200c more potentially mimicked retinoic acid on induction of stem cell neuronal differentiation [10] . Thus, miRNAs could control the proliferation and differentiation of ADSCs. In this study, the role of miR-142-5p in rat ADSCs neuronal proliferation and differentiation was explored. Our results showed that miR-142-5p represses the proliferation and differentiation of ADSCs, which may be mediated by targeting RhoA/ROCK1 signaling.
Materials and Methods

Cell culture and induction of neurogenic differentiation
This study was approved by the ethic committee of the Central South University. Human ADSCs were purchased from Invitrogene (Carlsbad, CA, USA) and cultured using the prepackaged MesenPRO RS™ Medium in an incubator with a humidified atmosphere and 5% CO 2 at 37°C. Passage 3 ADSCs were used for induction of differentiation.
Naive ADSCs cells or transfected ADSCs cells with miR-142-5p, RhoA, or ROCK1 shRNA were seeded in 12-well plates at a density of 5×10 4 cells/cm 2 . At 40% confluence, the cell culture was supplemented with 5μg/ml insulin, 0.5μM retinoic acid and 15ng/ml EGF for 2 days. Then, the culture medium was changed to the medium supplemented with 100μM cAMP, 500μM 3-isobutyl-1-methylxanthine (IBMX), 100ng/ml nerve growth factor (NGF) and 10μM forskolin for another 3 days.
Immunostaining
To assess neurogenic differentiation, the cells were stained with neuron-specific enolase (NSE), and Neuron-specific class III beta-tubulin (βIII tubulin). Briefly, cells were fixed with 4% paraformaldehyde for 20 min. Then the cells were permeabilized using PBS containing 0.5% Triton-X 100 (Sigma Aldrich) for 1 hour and then blocked using PBS supplemented with 4% BSA and 0.3% Triton-X 100 for another hour. After these treatments, the cells were incubated primary anti-NSE antibody (1:200, Abcam, Cambridge, MA, USA) or anti-βIII tubulin (1:200, Abcam) overnight at 4°C, followed by incubation with fluorescein isothiocyanate conjugated goat anti-rabbit antibody (1:5000 dilution, KPL) at room temperature for 60 min. Finally, the nuclei were stained with 5mg/ml DAPI for 15min and images were acquired using a fluorescence microscope (IX81; Olympus, Tokyo, Japan).
Reagents and cell transfection
The pLVmiR-142-5p expression plasmid, the pLVmiR-142-5p locker plasmid and the lentiviral packaging vector mix were purchased from Biosettia (San Diego, CA, USA). The lentiviral pLV-miR expression vector or the pLV-miR locker vectors were produced by co-transfection with helper plasmids mixture into HEK 293T cells using FuGene HD (Promega Corporation, Madison, WI) according to manufacturer's instruction. The ready-to-use human RhoA shRNA lentiviral particles and ROCK1 shRNA lentiviral particles were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA). To overexpress or suppress the genes, the ADSCs were infected with corresponding lentiviral particles with the presence of 8μg/ml polybrene (SigmaAldrich, MO, USA).
Taqman miRNAs array
ADSCs before induction, 2 days after induction and 5 days after the induction were used for microarray of miRNAs expression. Briefly, total miRNAs in the cell samples were extracted using the miRVana miRNA Isolation Kit (Ambion, Austin, TX, USA) according to the manufacturer's instructions. Then, TLDAv3.0 was performed as the manufacturer's protocol. All PCR reactions were performed on the 7900HT real-time PCR system (Applied Biosystems). Cycling conditions were as follows: 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. U6 snRNA was used as an internal control to normalize RNA input. The data were analyzed by SDS v2.3 software. In details, the Ct value is defined as the fractional cycle number at which the fluorescence passes the fixed threshold. The fold change was calculated using the 2 -ΔΔ CT method.
qRT-PCR analysis
Total RNAs of cells were extracted using Trizol Reagent (Invitrogen) according to the manufacturer's instruction. Then the RNA samples were used for reverse transcription to get the first strand cDNA by using the PrimeScript1 RT reagent kit (TaKaRa Bio, Dalian, China). The expressions of RhoA and ROCK1 mRNA and neurogenic markers NSE and β III tubulin were quantified using gene specific primers with SYBR1 Green PCRMaster Mix (TaKaRa Bio). GAPDH was used as the endogenous control gene. MiR-142-5p expression was detected using TaqMan MicroRNA Assay Kit (Applied Biosystems), with U6 snRNA used as the endogenous control. All qRT-PCR analysis was performed using an ABI Prism 7500 (Applied Biosystems). The results of qRT-PCR analysis were presented using 2 -ΔΔ CT method.
Cell viability and colony formation assay.
ADSCs were infected with pLV-miR-142-5p locker particles and/or RhoA and ROCK1 shRNA. After 24 h incubation, cells were placed in a fresh 96-well plate in triplicate for at least 5 days. Cells were tested for proliferation everyday using Cell Titer-Blue cell viability assay (Promega Corporation) according to the manufacturer's instructions and the fluorescence value was recorded by multi-plate reader (Synergy 2; BioTek, Winooski, VT). For CFU assay, transfected cells were placed in a fresh six-well plate in triplicate for 10 days. Then cell colonies were fixed with 20% methanol and stained with 0.1% coomassie brilliant blue R250 at room temperature for 15 min. The colonies were counted by ELIspot Bioreader 5000 (BIO-SYS, Karben, GE).
Dual luciferase assay
Chemically synthesized miR-142-5p mimics and the scramble negative controls were purchased from RiboBio (Guangzhou, China). The fragments of 3'-UTR of human RhoA and ROCK1 containing the putative miR-142-5p binding sequences was amplified with the primers RhoA: 5'-aaccttgctgcaagcacagcccttatgc-3' (forward) and 5'-tgagtgccacccatgagaactggtggctc-3' (reverse) or ROCK1: 5'-ctgagtgccctgtggaatcgtgtggg-3' (forward) and 5'-aatttgaagtatgttttccattcatttct-3' (reverse). The PCR products was cloned into firefly luciferase reporter vector pGL3 (Promega Corporation), termed as pGL3-RhoA-3'UTR and pGL3-ROCK1-3'UTR. The plasmids, which carried the mutated sequence in the complementary sites for the seed region of miR-142-5p (Fig. 4A) were generated based on pGL3-RhoA-3'UTR and pGL3-ROCK1-3'UTR plasmid by MutanBEST Kit (Takara Bio), termed as pGL3-RhoA-3'UTR mut and pGL3-ROCK1-3'UTR mut. The point mutations along the miR-142-5p seed binding sites were confirmed by sequencing analysis.
To assess the influence of putative miR-142-5p binding site on luciferase expression, HEK 293T cells were co-transfected with 200ng recombinant plasmids and 50nM miR-142-5p mimics or negative control (NC) using FuGene HD. The pRL-TK (Promega Corporation) was also transfected as a normalization control. 48h after transfection, luciferase activity was analyzed using the Dual-Luciferase Reporter Assay System (Promega Corporation) and recorded by multi-plate reader (Synergy 2; BioTek).
Western blot
Cells were lysed using a RIPA buffer (Beyotime, Shanghai, China) with 0.5% sodium dodecyl sulfate in the presence of proteinase inhibitor cocktail (Complete mini; Roche). Then the protein concentration was measured using a BCA Protein Assay Kit (Beyotime). Twenty-five micrograms of protein were separated by 10% SDS-PAGE mini gels and then transferred onto a PVDF membrane (Immobilon P -SQ ;Millipore, Billerica, MA). After blocking with 5% nonfat milk, the membranes were incubated with primary anti-RhoA (1:1000, Abcam), anti-ROCK1 (1:1000,Abcam) or anti-actin (1:5000, Epitomics, Burlingame, CA) at 4°C overnight, 
Prediction of miRNAs targets
To investigate the target genes of miRNAs and the conserved sites bound by the seed region of miR-142-5p, the TargetScan (http://www.targetscan.org/), PicTar (http://pictar.mdc-berlin.de/) and MiRanda (http://www.microrna.org/microrna/home.do) programs were used.
Statistical analysis
Data were presented in the form of means ± standard deviation (SD) based at least three repeats of three times independent studies. One-way ANOVA was performed to compare means of in multiple group experiments. Comparison between groups was performed using the unpaired t test. A two-sided P value of <0.05 was considered statistically significant.
Results
miR-142-5p is significantly upregulated during neurogenic differentiation of ADSCs
After the induction, the differentiation was visualized by immunofluorescent staining of neurogenic markers, including NSE and β III tubulin (Fig. 1A) . By Taqman miRNAs array, a series of miRNAs were found to be significantly desregulated during the induction process. The six most upregulated and six downregulated miRNAs are shown in Fig. 1B . Quantitative RT-PCR (qRT-PCR) analysis confirmed that miR-142-5p expression is consistently increased during the induction (Fig. 1C) .
miR-142-5p knockdown inhibits neurogenic differentiation and proliferation of ADSCs
To further verify the effect of miR-142-5p on neurogenic differentiation of ADSCs, the ADSCs were infected with pLV-miR-142-5p locker particles or the vector negative control (NC) (Fig 2A) . MiR-142-5p knockdown resulted in substantially decreased expression of NSE and β III tubulin mRNA after induction (Fig, 2B) . In addition, miR-142-5p knockdown also reduced the proportion of cells with positive NSE (51.8±4.7% vs. 27.4±3.6%) and β III tubulin (42.6±2.5% vs. 25.6±3.7%) after induction (Fig. 2C) , suggesting a repressed differentiation. Moreover, infection with pLV-miR-142-5p locker particles in ADSCs decreased the cell viability (Fig. 3A) . Colony-forming unit (CFU) assay also showed that the knockdown of miR-142-5p in ADSCs decreased the number of CFU (Fig. 3B) .
miR-142-5p directly targets RhoA and ROCK1
Based on prediction, it was found RhoA and ROCK1 had the putative binding sites with miR-142-5p (Fig. 4A) . In addition, miR-142-5p mimics repress the luciferase activity of wild type RhoA and ROCK1 3'UTR sequence, but not the mutant sequence in HEK293T cells (Fig. 4B) . In ADSCs, infection with pLV-miR-142-5p expression particles also significantly decreased RhoA and ROCK1 protein expression (Fig. 4C) . Moreover, RhoA and ROCK1 expression in the ADSCs during the induction process were significantly downregulated (Fig. 4D) . These results suggest that miR-142-5p can directly target RhoA and ROCK1, and regulate their expressions.
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RhoA/ROCK1 signaling pathway is involved in neurogenic differentiation and proliferation of ADSC by miR-142-5p
To further explore whether RhoA/ROCK signal is involved in miR-142-5p's regulation over neurogenic differentiation and proliferation of ADSCs, ADSCs were transfected with RhoA, ROCK1 or NC shRNA lentiviral particles before induction (Fig. 5A) . Knockdown of endogenous RhoA or ROCK1 partly restored the mRNA expressions of neuronal markers (NSE and β III tubulin) hampered by miR-142-5p shRNA (Fig. 5B) . Immunostaining analysis showed that RhoA and ROCK1shRNA, but not NC shRNA partly reversed the effect of miR-142-5p knockdown on repressing the proportion of ADSCs differentiation (Fig. 5C ). These results suggest that RhoA or ROCK1 shRNA rescued neurogenic differentiation hampered by miR-142-5p knockdown. CFU assay showed that RhoA and ROCK1shRNA partly reversed the effect of miR-142-5p knockdown on repressing cell proliferation in ADSCs (Fig. 5D ). Thus, it is possible that miR-142-5p can modulate neurogenic differentiation and proliferation of ADSCs by simultaneously repressing RhoA and ROCK1. 
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Discussion
ADSCs could transdifferentiate into neuron-like cells which present multiple neuronal properties, such as synaptic transmission, action potential, secretion of dopamine and neurotrophic factors, and spontaneous postsynaptic current [11, 12] . ADSCs stimulation enhanced axon regeneration by increased GAP-43 and activating transcription factor 3 (ATF-3) expression in the spinal cord and reduced c-jun expression in the dorsal root ganglia (DRG) neurons [13] . Human ADSC extract exert a potential therapeutic action in Amyotrophic lateral sclerosis (ALS) model by reducing apoptotic cell death and recovering mutant SOD1-induced mitochondrial dysfunction [14] . ADSCs differentiated Schwann cells have the ability to improve axonal regeneration and remyelination in rat spinal cord injury [15, 16] . Human ADSC extract ameliorated the effect of Aβ-induced mitochondrial oxidative stress and reduced the mitochondrial membrane potential, suggesting a therapeutic strategy to ameliorate neuronal death induced by Aβ [17, 18] . Thus, ADSCs might have potential therapeutic applications in the treatment of neurological diseases.
Previously, many miRNAs have been reported to play a role in the proliferation and differentiation of ADSCs, such as miR-let-7e, miR-154-5p, miR-218, miR-26a, miR-27, miR-31 and miR-34a [19] [20] [21] [22] [23] [24] [25] [26] [27] . Most recently, it was demonstrated that miR-124 is able to suppress Sp1 expression, which in turn affected the neuronal differentiation of mesenchymal stem cells [28] . miR-124 could directly target SCP1, which play a key role in the neuronal differentiation of ADSC [29] . In the present study, we found that the expression of miR-142-5p is consistently increased during the differentiation induction, together with the expression 
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Cellular Physiology and Biochemistry of neurogenic markers (NSE and β III tubulin). These findings suggested that miR-142-5p might be involved in neuronal-like differentiation of ADSCs. Some studies revealed that RhoA signaling pathway is involved in neuronal-like differentiation of MSCs [30] [31] [32] [33] . And Rho-kinase (ROCK) is an important downstream effector of RhoA modulating cell fate, which is also involved in MSCs differentiation [34, 35] . Actually, the RhoA /ROCK1signaling pathway might be quite critical for neuronallike differentiation of MSCs. For example, miR-125a-3p and miR-483-5p can promote adipogenesis of ADSCs via suppressing the RhoA/ROCK1/ERK1/2 pathway [36] . MiR-335-5p can promote chondrogenesis of mouse MSCs by downregulating Daam1 and ROCK1 and increasing SOX9 [37] . Our preliminary study observed that miR-142-5p have the putative binding sites with 3'UTRs of RhoA and ROCK1 mRNA. Therefore, we hypothesized that miR-142-5p can modulate neuronal-like differentiation of ADSCs through repressing RhoA and ROCK1. By dual luciferase assay and western blot, these targetings were verified. In addition, Knockdown of endogenous RhoA and ROCK1, partly rescued neuronal differentiation and proliferation hampered by knockdown of miR-142-5p. Thus, miR-142-5p regulating RhoA/ ROCK1 is an important axis involved in neuronal-like differentiation of ADSCs.
Previous studies have reported that the D1 dopamine receptor post-transcriptional regulation is specifically mediated by miR-142-3p in the mouse brain during postnatal development [38] . MiR-142 is overexpressed in neurons, which may contribute to the changes in dopaminergic neurotransmission by regulating SIRT1 and MAOA genes in HIV-associated neurocognitive disorders (HAND) [39, 40] . MiR-142-5p is localized to neurons and negatively regulates neuronal morphogenesisby targeting Ulk1 in porcine hemagglutinating encephalomyelitis (PHE) [41] . MiR-142-5p contributes the pathogenesis of Alzheimer's disease (AD) by triggering synaptic dysfunction associated with Aβ42-mediated pathophysiology [42] . Therefore, miR-142-5p might play a critical role in neuronal process.
Conclusion
In this study, we found that miR-142-5p targets RhoA/ROCK1 signaling, which is involved in differentiation and proliferation of ADSCs for the first time. We also demonstrated that the miR-142-5p/RhoA/ROCK1 is an important signaling pathway in the differentiation. These findings provided some fundamental information for future use of ADSCs as an agent for regenerative medicine and cell therapy for neurological diseases.
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